Insider Stock Transactions
| Date |
Name |
Title |
Type |
Shares Traded |
Price Range |
| 08-05-09 |
mills c randal |
Officer |
Disposition (Non Open Market) |
500 |
12.23 |
| 05-14-09 |
debrabandere lode |
Officer |
Sell |
37,500 |
12.49 |
| 05-14-09 |
debrabandere lode |
Officer |
Option Execute |
37,500 |
6.84 |
| 02-23-09 |
barnhill gregory hurd |
Director |
Acquisition (Non Open Market) |
5,000 |
18.60 |
| 02-23-09 |
friedli peter |
Director |
Acquisition (Non Open Market) |
10,000 |
18.60 |
| 02-23-09 |
gutzwiller felix |
Director |
Acquisition (Non Open Market) |
3,500 |
18.60 |
| 02-23-09 |
moyes jay m |
Director |
Acquisition (Non Open Market) |
3,000 |
18.60 |
| 12-08-08 |
carmitchel harry e |
Officer |
Sell |
7,000 |
19.46 |
| 12-03-08 |
carmitchel harry e |
Officer |
Sell |
5,000 |
20.35 |
| 11-14-08 |
friedli peter |
Director |
Buy |
205,423 |
12.17 |
| 11-14-08 |
venturetec inc |
Beneficial Owner (10% or more) |
Buy |
189,681 |
13.18 |
| 10-16-08 |
jacoby philip r jr |
Officer |
Option Execute |
3,125 |
0.40 |
| 09-16-08 |
friedli peter |
Director |
Disposition (Non Open Market) |
1,000,000 |
n/a |
| 07-03-08 |
fender earl r |
Other |
Buy |
37,500 |
6.84 |
| 03-05-08 |
carmitchel harry e |
Officer |
Disposition (Non Open Market) |
7,500 |
10.36 |
| 02-04-08 |
barnhill gregory hurd |
Director |
Acquisition (Non Open Market) |
5,000 |
12.01 |
| 02-04-08 |
friedli peter |
Director |
Acquisition (Non Open Market) |
10,000 |
12.01 |
| 02-04-08 |
friedli peter |
Director |
Disposition (Non Open Market) |
1,000 |
12.01 |
| 02-04-08 |
friedli peter |
Director |
Acquisition (Non Open Market) |
29,741 |
n/a |
| 02-04-08 |
gutzwiller felix |
Director |
Acquisition (Non Open Market) |
3,500 |
12.01 |
|
|
Stock transaction information provided by EDGAR Online.
Osiris Therapeutics makes no representation or warranty with respect any of to
the information contained herein, takes no responsibility for
supplementing, updating or correcting any such information and shall have
no liability with respect to any such information. This listing does not
include derivatives, such as stock option grants or shares purchased
through an employee stock purchase plan. For recent transactions, including
derivative transactions, see our
Section 16 SEC filings page.
